4.2 Article

A novel TUBB3 mutation in a sporadic patient with asymmetric cortical dysplasia

期刊

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 170, 期 4, 页码 1076-1079

出版社

WILEY-BLACKWELL
DOI: 10.1002/ajmg.a.37545

关键词

malformation of cortical development (MCD); beta-tubulin class III (TUBB3); tubulin family; mutation

资金

  1. Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency
  2. Japan Society for the Promotion of Science [24791090]
  3. Japan Epilepsy Research Foundation
  4. Kanae Foundation
  5. Japan Agency for Medical Research and Development
  6. JSPS KAKENHI [15K09631]
  7. Grants-in-Aid for Scientific Research [15K09631, 24791090] Funding Source: KAKEN

向作者/读者索取更多资源

Recent advances in molecular technology have led to the discovery of several genes related to human malformations of cortical development (MCDs). The beta-tubulin class III gene (TUBB3) was identified as a gene responsible for MCDs. Although mouse-model experiments have not revealed any findings of neuronal migration disorders, human TUBB3 mutations have been identified in patients with congenital fibrosis of the extraocular muscles. Since the discovery of a TUBB3 mutation, only 15 mutations have been identified. In this study, comprehensive mutation screening through next-generation sequencing identified a novel TUBB3 mutation (p.Ser230Leu) in a sporadic patient with moderate developmental delay associated with mild MCD. Compared to patients with the alpha-tubulin class 1a gene (TUBA1A) mutations, patients with TUBB3 mutations show milder phenotypic manifestations and milder MCD. Therefore, patients with milder MCD manifestations may be under-diagnosed, and TUBB3 mutations may be rarely identified. Additional genotype-phenotype information should be accumulated for further understanding of the TUBB3 functional relevance. (c) 2016 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据